SERPINA1 and chronic obstructive pulmonary disease: Regarding augmented Pi*ZZ patients, the higher EIA can be attributed in part to the exogenous AAT from the augmentation therapy, but since they also have COPD, the increased EIA/AAT ratio may also be associated with the presence of other antiproteases, as in non-AATD related COPD.